- Home
- STE vs ZBH Comparison
STE vs ZBH Comparison
Compare STE & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STE
- ZBH
- Stock Information
- Founded
- STE 1985
- ZBH 1927
- Country
- STE United States
- ZBH United States
- Employees
- STE N/A
- ZBH N/A
- Industry
- STE Industrial Specialties
- ZBH Industrial Specialties
- Sector
- STE Health Care
- ZBH Health Care
- Exchange
- STE Nasdaq
- ZBH Nasdaq
- Market Cap
- STE 22.1B
- ZBH 20.8B
- IPO Year
- STE 1992
- ZBH N/A
- Fundamental
- Price
- STE $213.40
- ZBH $108.80
- Analyst Decision
- STE Buy
- ZBH Hold
- Analyst Count
- STE 6
- ZBH 21
- Target Price
- STE $253.00
- ZBH $123.58
- AVG Volume (30 Days)
- STE 695.3K
- ZBH 1.6M
- Earning Date
- STE 11-06-2024
- ZBH 10-30-2024
- Dividend Yield
- STE 1.08%
- ZBH 0.88%
- EPS Growth
- STE N/A
- ZBH 132.72
- EPS
- STE 4.37
- ZBH 5.26
- Revenue
- STE $5,325,525,000.00
- ZBH $7,595,500,000.00
- Revenue This Year
- STE $8.04
- ZBH $4.76
- Revenue Next Year
- STE $6.32
- ZBH $4.63
- P/E Ratio
- STE $48.56
- ZBH $20.79
- Revenue Growth
- STE 15.75
- ZBH 4.35
- 52 Week Low
- STE $195.47
- ZBH $101.47
- 52 Week High
- STE $248.24
- ZBH $133.90
- Technical
- Relative Strength Index (RSI)
- STE 32.18
- ZBH 52.68
- Support Level
- STE $208.95
- ZBH $108.25
- Resistance Level
- STE $224.09
- ZBH $114.72
- Average True Range (ATR)
- STE 5.20
- ZBH 2.10
- MACD
- STE -0.81
- ZBH 0.06
- Stochastic Oscillator
- STE 12.51
- ZBH 29.06
About STE STERIS plc (Ireland)
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.